Here, NF-κB is commonly observed to be constitutively active in GBM in turn, driving, amongst others, GBM invasiveness, angiogenesis, and resistance to radiotherapy (reviewed in [13,14]). This evidence concerns the gene NFKB1 and glioblastoma.